基本信息
浏览量:13
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Dr. Holtorf is the founder of Health Outcomes Strategies. Her areas of expertise is value based market access strategies for the Life-Science Industry including policy decisions on healthcare products, reimbursement strategies, outcomes research and health economics, health technology assessment processes, payer interactions, product / service synergies.
Dr. Holtorf has served as visiting faculty at the University of Utah between 2006 and 2007 and remains adjunct faculty in the Pharmacotherapy Outcomes Research Center at the University of Utah College of Pharmacy, where she in addition to her academic contributions participated as investigator in a variety of outcomes studies. She has published broadly, among others on subjects of evidence based decision making and quality control in healthcare. As member of the Health Technology Assessment international Association (HTAi) and the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) she is engaged in the Health Technology Assessment working groups for pharmaceuticals, medical devices and diagnostics and in the Personalized Medicine workgroup. Dr. Holtorf has also been appointed as evaluator at the EU-commission on multiple occasions.
Dr. Holtorf obtained her PhD in natural sciences from the University of Marburg (Germany) and her MBA from the University of Birmingham (United Kingdom). She looks back on over 20 years of experience in the pharmaceutical and chemical industry in research and marketing with global responsibilities. Among others, she was responsible for the global Disease Management strategy and activities of Novartis Pharma, AG. Between 2000 and 2004, Dr. Holtorf managed the biotech business unit of a midsized Swiss chemical company and held a seat in the executive committee.
研究兴趣
论文共 54 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Zsombor Zrubka, Annette Champion,Anke-Peggy Holtorf,Rossella Di Bidino,Jagadeswara Rao Earla, Artem T. Boltyenkov,Masami Tabata-Kelly,Carl Asche,Anita Burrell
International Journal of Technology Assessment in Health Careno. S1 (2023)
Anke-Peggy Holtorf,Andriy Danyliv,Li-Ying Huang,Yvette Venable,Alissa Hanna, Annekatrin Krause,Miranda Pierre,Donna Walsh,Aline Silveira Silva,Sou-Hyun Lee, T Joseph Mattingly Ii
International journal of technology assessment in health careno. 1 (2023): 1-29
Zsombor Zrubka, Champion Annette,Rossella Di Bidino,Anke-Peggy Holtorf, Jagadeswara R Earla, Artem Boltyenkov,Masami Tabata-Kelly, Carl Victor Asche,Anita Burrell
International Journal of Technology Assessment in Health Careno. S1 (2023)
Anke-Peggy Holtorf,Andriy Danyliv, Annekatrin Krause,Alissa Hanna,Yvette Venable,T Joseph Mattingly,Li-Ying Huang, Miranda Pierre,Aline Silveira Silva,Donna Walsh
International journal of technology assessment in health careno. 1 (2023)
Diana Brixner,Anke-Peggy Holtorf, Ayesha Bhatia,Bhagyashree Oak, Sumudu Dehipawala,Clive Whitcher, Kate McKinley, Kyle Martin,Nandini Hadker
Pharmacoeconomics: Principles and Practicepp.77-98, (2022)
Anita Burrell,Zsombor Zrubka, Annette Champion,Vladimir Zah,Laura Vinuesa,Anke-Peggy Holtorf,Rossella Di Bidino,Jagadeswara Rao Earla, Joanna Entwistle,Artem Tarasovic Boltyenkov, George Braileanu,Katarzyna Kolasa,
Anke-Peggy Holtorf,Erna Kristin, Anunchai Assamawakin,Nilawan Upakdee, Rina Indrianti, Napassorn Apinchonbancha
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn